Serum galectin-3 levels are decreased in schizophrenia.


Creative Commons License

Kiliç F., Işik Ü., Demirdaş A., Usta A.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), cilt.42, ss.398-402, 2020 (SCI-Expanded, SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1590/1516-4446-2019-0699
  • Dergi Adı: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, Academic Search Premier, Fuente Academica Plus, BIOSIS, EMBASE, MEDLINE, Psycinfo, Directory of Open Access Journals
  • Sayfa Sayıları: ss.398-402
  • Anahtar Kelimeler: Schizophrenia, galectin-3, serum level, neuroinflammation, EXPRESSION, CYTOKINE, ANGIOGENESIS, INFLAMMATION, PSYCHOSIS, SEVERITY, SYMPTOMS, CELLS
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Süleyman Demirel Üniversitesi Adresli: Evet

Özet

Objective: To determine whether changes in serum galectin-3 (gal-3) concentrations in schizophrenia patients have etiopathogenetic importance. Since very little research has assessed the connection between galectins and schizophrenia, we wanted to examine alterations in the inflammatory marker gal-3 in schizophrenia and investigate possible correlations between clinical symptomatology and serum concentrations.